Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Synjardy (empagliflozin;metformin) — Boehringer Ingelheim
Synjardy (empagliflozin; metformin) has been authorised by EMA for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes. [NA]
Randomized trial results for a novel intervention to improve care for people with type 2 diabetes; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
A completed clinical trial investigating anti-inflammatory properties of cannabis and their relation to insulin sensitivity in individuals w…
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
A completed clinical trial evaluating cardiovascular outcomes in bariatric surgery patients with type 2 diabetes, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight [Phase 3]
Phase 3 trial evaluating retatrutide (LY3437943) for type 2 diabetes in participants with obesity or overweight has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Update: A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing HRS9531 to semaglutide as add-on therapy to metformin (with or without SGLT2 inhibitors) in adults with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: Uric Acid Lowering Trial in Youth Onset T2D [Phase 2]
Phase 2 trial results for an uric acid-lowering therapy in youth-onset type 2 diabetes; study is completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1 [NA]
A completed clinical trial evaluating financial incentives and nurse coaching to improve outcomes in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both [Phase 3]
A Phase 3 trial comparing CagriSema to Tirzepatide in adults with Type 2 diabetes on metformin and/or SGLT2 inhibitors, completed.
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 trial results for LY3502970 in Japanese participants with Type 2 diabetes mellitus have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-14Clinical Trial Update: the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of HRS9531 injection in adults with type 2 diabetes inadequately controlled with di…
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating finerenone with empagliflozin versus each monotherapy in adults with type 2 diabetes and chronic kidney disease; re…
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity [NA]
A completed clinical trial investigating whether physical activity reduces metabolic dysregulation in obese Latina breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing tirzepatide with dulaglutide on major cardiovascular events in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Diabetes Care for Breast Cancer Patients [NA]
A completed trial evaluating diabetes care in breast cancer patients, including those with prediabetes and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: PROmoting Diabetes Education and Management Through Peer Support and Team Referral [NA]
Completed clinical trial evaluating peer support and team referral to promote diabetes education and management in type 2 diabetes patients;…
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus [NA]
A completed clinical trial assessing muscle and tendon dysfunction in people with Type 2 Diabetes Mellitus, with results posted.
-
EMA approval · 2026-07-02EMA Authorised: Suliqua (insulin glargine;lixisenatide) — Sanofi Winthrop Industrie
Suliqua (insulin glargine and lixisenatide) has been authorised for type 2 diabetes mellitus in the European Union.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing switching from daily basal insulin (glargine) to weekly insulin icodec in adults with type 2 diabetes, assessing imp…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes [Phase 3]
Phase 3 long-term safety results for orforglipron (LY3502970) in adults with Type 2 Diabetes have been completed and results posted, focusin…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Update: A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin [Phase 3]
A Phase 3 trial comparing HRS-7535 with dapagliflozin in adults with Type 2 diabetes inadequately controlled with metformin has completed.
-
EMA approval · 2026-06-25EMA Authorised: Trajenta (linagliptin) — Boehringer Ingelheim International GmbH
Trajenta (linagliptin) has been authorised for use in the European Union for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Clinical trial results for early GLP-1 receptor agonist and SGLT2 inhibitor add-on strategies in adults with obesity, type 2 diabetes, cardi…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Update: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight [Phase 3]
Phase 3 trial update evaluating Survodutide (BI 456906) for weight loss in people with overweight/obesity and type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery Disease [NA]
Trial comparing standard care versus case-managed care for diabetes in patients with coronary artery disease; results posted after completio…